Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
313.74
+17.71 (5.98%)
At close: May 12, 2025, 4:00 PM
312.51
-1.23 (-0.39%)
After-hours: May 12, 2025, 7:45 PM EDT
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $9.02 billion as of May 12, 2025. Its market cap has decreased by -26.79% in one year.
Market Cap
9.02B
Enterprise Value
8.73B
1-Year Change
-26.79%
Ranking
Category
Stock Price
$313.74
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $9.02B, an increase of 718.50%. That is a compound annual growth rate of 27.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 8.51B | -17.60% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |